Argyle Capital Management Inc. Bristol Myers Squibb CO Transaction History

Argyle Capital Management Inc.

$271 Million
Q2 2025

A detailed history of Argyle Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Argyle Capital Management Inc. holds 68,852 shares of BMY stock, worth $3.16 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

68,852

Previous 68,747 0.15%

Holding current value

$3.16 Million

Previous $4.19 Million 23.97%

% of portfolio

1.17%

Previous 1.58%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$44.12 - $59.6 $4,632 - $6,258	105 Added 0.15%	68,852 $3.19 Million
Q1 2025 Apr 29, 2025	BUY	$53.9 - $63.11 $74,382 - $87,091	1,380 Added 2.05%	68,747 $4.19 Million
Q4 2024 Feb 05, 2025	BUY	$51.92 - $59.94 $132,396 - $152,847	2,550 Added 3.93%	67,367 $3.81 Million
Q3 2024 Oct 25, 2024	BUY	$39.66 - $51.75 $29,744 - $38,812	750 Added 1.17%	64,817 $3.35 Million
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $55,746 - $73,391	-1,385 Reduced 2.12%	64,067 $2.66 Million
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $40,015 - $45,369	834 Added 1.29%	65,452 $3.55 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $395,112 - $471,477	-8,150 Reduced 11.2%	64,618 $3.32 Million
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $262,531 - $293,550	4,535 Added 6.65%	72,768 $4.22 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $348,812 - $387,301	-5,475 Reduced 7.43%	68,233 $4.36 Million
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $24,049 - $27,277	-366 Reduced 0.49%	73,708 $5.11 Million
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $6 - $3,842	-50 Reduced 0.07%	74,074 $5.27 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $43,572 - $47,988	-600 Reduced 0.8%	74,124 $5.71 Million
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $258,216 - $309,624	-4,200 Reduced 5.32%	74,724 $5.46 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $7,506 - $8,505	-130 Reduced 0.16%	78,924 $4.9 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $45,944 - $50,912	-800 Reduced 1.0%	79,054 $4.77 Million
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $18,309 - $21,406	-334 Reduced 0.42%	79,854 $4.7 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $6,960 - $10,114	-150 Reduced 0.19%	80,188 $4.47 Million
Q4 2019 Jan 24, 2020	SELL	$49.21 - $64.19 $40,352 - $52,635	-820 Reduced 1.01%	80,338 $5.16 Million
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $23,523 - $27,890	550 Added 0.68%	81,158 $4.12 Million
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $11,155 - $12,335	250 Added 0.31%	80,608 $3.66 Million
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $73,140 - $94,845	-1,500 Reduced 1.83%	80,358 $4.18 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $12,632 - $15,745	-250 Reduced 0.3%	81,858 $4.53 Million
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $152,796 - $175,899	-2,550 Reduced 3.01%	82,108 $5.19 Million
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $4.68 Million - $5.4 Million	84,658	84,658 $5.4 Million

Others Institutions Holding BMY

# of Institutions

2,677

Shares Held

1.58B

Call Options Held

25.9M

Put Options Held

24.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Bristol Myers Squibb CO Transaction History